Results 171 to 180 of about 4,219,504 (325)
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source
Hypoglycemic coma owing to sensor device dysfunction after an automatic smartphone operating system update. [PDF]
Sato T +4 more
europepmc +1 more source
ABSTRACT Objective Accurate localization of epileptogenic tubers (ETs) in patients with tuberous sclerosis complex (TSC) is essential but challenging, as these tubers lack distinct pathological or genetic markers to differentiate them from other cortical tubers.
Tinghong Liu +11 more
wiley +1 more source
An operating system for executing applications on quantum network nodes. [PDF]
Delle Donne C +24 more
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Dataset of Windows operating system forensics artefacts. [PDF]
Marková E +3 more
europepmc +1 more source
Discussion: “Determination of System Characteristics from Normal Operating Records” (Goodman, T. P., and Reswick, J. B., 1956, Trans. ASME, 78, pp. 259–268) [PDF]
J. M. Loeb
openalex +1 more source

